CA2024855A1 - Process and intermediates for producing glucagon - Google Patents

Process and intermediates for producing glucagon

Info

Publication number
CA2024855A1
CA2024855A1 CA 2024855 CA2024855A CA2024855A1 CA 2024855 A1 CA2024855 A1 CA 2024855A1 CA 2024855 CA2024855 CA 2024855 CA 2024855 A CA2024855 A CA 2024855A CA 2024855 A1 CA2024855 A1 CA 2024855A1
Authority
CA
Canada
Prior art keywords
glucagon
intermediates
producing glucagon
fragments
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2024855
Other languages
French (fr)
Other versions
CA2024855C (en
Inventor
Jean-Andre Gauthier
Nedumparambil A. Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Bio Mega Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Inc filed Critical Bio Mega Inc
Priority to CA 2024855 priority Critical patent/CA2024855C/en
Publication of CA2024855A1 publication Critical patent/CA2024855A1/en
Application granted granted Critical
Publication of CA2024855C publication Critical patent/CA2024855C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein is an improved process for preparing the nonacosapeptide glucagon. The process comprises the serial coupling of two highly purified fragments, glucagon(15-22) and glucagon(7-14) fragments, to a modified glucagon(23-29) fragment having a benzhydrylamine type resin attached to the .omega.-carboxyl of Asp at position 28.
CA 2024855 1990-09-07 1990-09-07 Process and intermediates for producing glucagon Expired - Fee Related CA2024855C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2024855 CA2024855C (en) 1990-09-07 1990-09-07 Process and intermediates for producing glucagon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2024855 CA2024855C (en) 1990-09-07 1990-09-07 Process and intermediates for producing glucagon

Publications (2)

Publication Number Publication Date
CA2024855A1 true CA2024855A1 (en) 1992-03-08
CA2024855C CA2024855C (en) 1997-12-09

Family

ID=4145922

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2024855 Expired - Fee Related CA2024855C (en) 1990-09-07 1990-09-07 Process and intermediates for producing glucagon

Country Status (1)

Country Link
CA (1) CA2024855C (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338368B2 (en) 2005-11-07 2012-12-25 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
US8450270B2 (en) 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
US8454971B2 (en) 2007-02-15 2013-06-04 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8507428B2 (en) 2010-12-22 2013-08-13 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity
US8546327B2 (en) 2008-06-17 2013-10-01 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8551946B2 (en) 2010-01-27 2013-10-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US8669228B2 (en) 2007-01-05 2014-03-11 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8729017B2 (en) 2011-06-22 2014-05-20 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8778872B2 (en) 2010-06-24 2014-07-15 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
US8859491B2 (en) 2011-11-17 2014-10-14 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
US8969288B2 (en) 2008-12-19 2015-03-03 Indiana University Research And Technology Corporation Amide based glucagon and superfamily peptide prodrugs
US8980830B2 (en) 2007-10-30 2015-03-17 Indiana University Research And Technology Corporation Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
US8981047B2 (en) 2007-10-30 2015-03-17 Indiana University Research And Technology Corporation Glucagon antagonists
US9062124B2 (en) 2008-06-17 2015-06-23 Indiana University Research And Technology Corporation GIP-based mixed agonists for treatment of metabolic disorders and obesity
US9127088B2 (en) 2010-05-13 2015-09-08 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
US9145451B2 (en) 2010-05-13 2015-09-29 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhbiting G protein coupled receptor activity
US9150632B2 (en) 2009-06-16 2015-10-06 Indiana University Research And Technology Corporation GIP receptor-active glucagon compounds
US9156902B2 (en) 2011-06-22 2015-10-13 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US9340600B2 (en) 2012-06-21 2016-05-17 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018164B2 (en) 2005-11-07 2015-04-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
US8338368B2 (en) 2005-11-07 2012-12-25 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
US8669228B2 (en) 2007-01-05 2014-03-11 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
US8454971B2 (en) 2007-02-15 2013-06-04 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8900593B2 (en) 2007-02-15 2014-12-02 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US9447162B2 (en) 2007-02-15 2016-09-20 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8981047B2 (en) 2007-10-30 2015-03-17 Indiana University Research And Technology Corporation Glucagon antagonists
US8980830B2 (en) 2007-10-30 2015-03-17 Indiana University Research And Technology Corporation Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
US9062124B2 (en) 2008-06-17 2015-06-23 Indiana University Research And Technology Corporation GIP-based mixed agonists for treatment of metabolic disorders and obesity
US8546327B2 (en) 2008-06-17 2013-10-01 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8450270B2 (en) 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
US8969288B2 (en) 2008-12-19 2015-03-03 Indiana University Research And Technology Corporation Amide based glucagon and superfamily peptide prodrugs
US9150632B2 (en) 2009-06-16 2015-10-06 Indiana University Research And Technology Corporation GIP receptor-active glucagon compounds
US9790263B2 (en) 2009-06-16 2017-10-17 Indiana University Research And Technology Corporation GIP receptor-active glucagon compounds
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8551946B2 (en) 2010-01-27 2013-10-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US9487571B2 (en) 2010-01-27 2016-11-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US9127088B2 (en) 2010-05-13 2015-09-08 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
US9145451B2 (en) 2010-05-13 2015-09-29 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhbiting G protein coupled receptor activity
US9783592B2 (en) 2010-05-13 2017-10-10 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
US8778872B2 (en) 2010-06-24 2014-07-15 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
US8507428B2 (en) 2010-12-22 2013-08-13 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity
US9249206B2 (en) 2010-12-22 2016-02-02 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity
US8729017B2 (en) 2011-06-22 2014-05-20 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US9309301B2 (en) 2011-06-22 2016-04-12 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US9758562B2 (en) 2011-06-22 2017-09-12 Indiana University and Technology Corporation Glucagon/GLP-1 receptor co-agonists
US9156902B2 (en) 2011-06-22 2015-10-13 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US10174093B2 (en) 2011-06-22 2019-01-08 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US10730923B2 (en) 2011-06-22 2020-08-04 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8859491B2 (en) 2011-11-17 2014-10-14 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
US9340600B2 (en) 2012-06-21 2016-05-17 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity

Also Published As

Publication number Publication date
CA2024855C (en) 1997-12-09

Similar Documents

Publication Publication Date Title
CA2024855A1 (en) Process and intermediates for producing glucagon
AU7007491A (en) Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
AU7116691A (en) Process for the preparation of oxetanones
CA2138137A1 (en) Diphtheria toxin vaccines
AU567730B2 (en) Polyarylnitrile polymers
HU9502640D0 (en) Phosphorus-modified epoxy resins, process for producing them and their use
AU3481189A (en) Improved process for the production of perfluoropolyethers substantially constituted by perfluorooxyethylene and perfluorooxypropylene units
AU5265296A (en) Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology
IE872523L (en) A process for the preparation of a hydrolyzed lecithin, and¹use of the hydrolyzed lecithin
AU6307094A (en) Process for producing raw rubber
HU894117D0 (en) Process for producing hirudine-like peptones
IE861259L (en) DIHYDRO-DIBENZO £a,d| CYCLOHEPTENES
HK1003229A1 (en) Carrier-bound recombinant portein process for producing it and its use as an immunogen and vaccine
CA2027246A1 (en) Key stone set
HU904835D0 (en) Process for the production of crystallic r-h-gm-csf
WO1990006943A3 (en) Novel tnf peptides
AU4462589A (en) Improved process for the production of hydrocarbon-aromatic hydroxyl-containing resins
AU8177791A (en) New embodiments of the hiv principal neutralizing determinant
AU2456588A (en) Glass shaping fabric liner
EP0714513A4 (en) Molecular clones producing recombinant dna antigens of the hards virus
AU5347490A (en) Process for producing norcamphanedicarbonitriles
HUT44620A (en) Human, low-affinity fc under epsilon receptor and process for the isolation, production by recombinant technique and cleaning thereof
EP0393611A3 (en) Novel process for producing oxetanocin g
HU902500D0 (en) Process for producing intermediaries of n,n'-diacyl-aminales
AU5390590A (en) Substituted biphenylcarboxylic acids, a process for their preparation and novel intermediates

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed